View source for 20250154278. Optimized Antibodies (JANUX THERAPEUTICS, INC.)

= OPTIMIZED ANTIBODIES TARGETING TROP2 AND USES THEREOF =

'''Abstract''':
disclosed herein are recombinant antibodies or antigen binding fragments thereof that comprise a tumor-associated calcium signal transducer 2 (trop2) binding domain that has been optimized for binding and kinetic properties. in some embodiments, the recombinant antibodies or antigen binding fragments thereof further comprise a cd3 binding domain.

'''Inventor(s)''': [[:Category:David CAMPBELL of San Diego CA US|David CAMPBELL]], [[:Category:Thomas R. DIRAIMONDO of San Diego CA US|Thomas R. DIRAIMONDO]]

'''CPC Classification''': [[:Category:CPC_C07K16/30|C07K16/30]] (PEPTIDES  (peptides in foodstuffs ; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs ; preparations for medicinal purposes ; peptides containing beta-lactam rings ; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, ; ergot alkaloids of the cyclic peptide type ; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids ; macromolecular products derived from proteins ; preparation of glue or gelatine ; single cell proteins, enzymes ; genetic engineering processes for obtaining peptides ; compositions for measuring or testing processes involving enzymes ; investigation or analysis of biological material ))


[[Category:Patent Applications]]
[[Category:JANUX THERAPEUTICS, INC.]]
[[Category:CPC_C07K16/30]]
[[Category:David CAMPBELL of San Diego CA US]]
[[Category:Thomas R. DIRAIMONDO of San Diego CA US]]

[https://wikipatents.org/index.php?search=20250154278+rejection&title=Special%3ASearch&wprov=acrw1_-1 Search for rejections for patent application number 20250154278]


<!-- JSON-LD markup for search engines:
{"@context":"https://schema.org","@type":"TechArticle","headline":"20250154278. Optimized Antibodies (JANUX THERAPEUTICS, INC.)","name":"20250154278. Optimized Antibodies (JANUX THERAPEUTICS, INC.)","description":"Patent application abstract and classification for 20250154278 - Optimized Antibodies ","datePublished":"2025-05-23","mainEntity":{"@type":"GovernmentPermit","permitType":"Patent Application","identifier":"20250154278","name":"Optimized Antibodies ","additionalProperty":[{"@type":"PropertyValue","name":"Organization","value":"JANUX THERAPEUTICS, INC."}]}}
-->